Texas Retina Dallas Research Team Recognized for Highest Site Enrollment Globally in Geographic Atrophy Clinical Trial
Under the leadership of Principal Investigator Dr. Ashkan M. Abbey, the Texas Retina Dallas research team was recently named the top enroller for Part I of the DFI18231 study, which is evaluating
read more
Texas Retina First in the US to Randomize a Patient in the i-SIGHT2 Bioelectric Therapy for Dry AMD Clinical Trial
The i-SIGHT2 pivotal clinical trial is evaluating the investigational i-Lumen AMD System for patients with intermediate to advanced dry age-related macular degeneration (AMD), and on July 1, 2026, Texas Retina’s Patrick D.
read more
Dr. Williams Receives Honor Award from the American Society of Retina Specialists
Texas Retina’s Patrick D. Williams, MD, has earned the Honor Award from the American Society of Retina Specialists (ASRS) in recognition of his time and contributions to the scientific programs of the
read more
Texas Retina Team Publishes Results of COED Trial for Diabetic Macular Edema
A prospective, randomized, comparative trial conducted exclusively at Texas Retina, the COED study compared two treatment regimens for diabetic macular edema (DME): a combination of an intravitreal dexamethasone implant (Ozurdex) and aflibercept
read more
Meet Our Fort Worth Clinical Research Coordinators
Lori Hastings and Tina Bell serve as the clinical research coordinators for our Fort Worth office, managing the enrollment and participation of patients in our clinical trials. These studies explore promising new
read more
Seven Texas Retina Associates Physicians Earn New Professional Designation
The American Society of Retina Specialists has awarded its Fellow of the ASRS (FASRS) designation to the following Texas Retina Associates physicians: David Callanan, MD Rajiv Anand, MD Michel J. Shami, MD
read more
Dr. Abbey and Dr. Williams Co-authored Article Published in Ophthalmology on the Influence of Face Mask Use on Endophthalmitis Risk After Eye Injections
Texas Retina Associates’ Ashkan Abbey, MD, and Patrick D. Williams, MD, co-authored a recently published article titled “The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During
read more Texas Retina Associates Participating in Pagoda Clinical Trial for Diabetic Macular Edema
Sponsored by Genentech, the Pagoda clinical trial is studying an investigational drug delivery system for diabetic macular edema (DME) treatment to see if it could result in fewer eye injections and eye
read more
Getting to Know Patrick Williams, MD
Originally from Santa Maria, California, Patrick Williams, MD, met fellow Texas Retina Associates physician Christopher Fuller, MD, in medical school at Texas Tech in Lubbock. That led to the opportunity to shadow
read more
Texas Retina Associates Held 18th Annual Vitreoretinal Disease Update for Optometrists
On May 5, 2019, 180 optometrists attended Texas Retina Associates’ Vitreoretinal Disease Update 2019, an annual continuing education event held this year at the Fogelson Forum at Texas Health Presbyterian Hospital Dallas.
read more